Hemorrhagic Shock Global Clinical Trials Review, H2, 2013

Share Article

Reportbuyer.com just published a new market research report: Hemorrhagic Shock Global Clinical Trials Review, H2, 2013.

Hemorrhagic Shock Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, “Hemorrhagic Shock Global Clinical Trials Review, H2, 2013" provides data on the Hemorrhagic Shock clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemorrhagic Shock. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hemorrhagic Shock. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

-Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
-Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
-Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

-Understand the dynamics of a particular indication in a condensed manner
-Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
-Obtain discontinued trial listing for trials across the globe
-Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hemorrhagic Shock 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Hemorrhagic Shock 23
Subjects Recruited Over a Period of Time 24
Prominent Sponsors 25
Top Companies Participating in Hemorrhagic Shock Therapeutics Clinical Trials 27
Prominent Drug Comparison 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Sangart, Inc. 30
Clinical Trial Overview of Sangart, Inc. 30
AstraZeneca PLC 31
Clinical Trial Overview of AstraZeneca PLC 31
Shenzhen Neptunus Pharmaceutical Company Limited 32
Clinical Trial Overview of Shenzhen Neptunus Pharmaceutical Company Limited 32
Health Ricerca e Sviluppo S.r.l 33
Clinical Trial Overview of Health Ricerca e Sviluppo S.r.l 33
Innogene Kalbiotech Pte. Ltd. 34
Clinical Trial Overview of Innogene Kalbiotech Pte. Ltd. 34
Northfield Laboratories Inc. (Inactive) 35
Clinical Trial Overview of Northfield Laboratories Inc. (Inactive) 35
Oxygen Biotherapeutics, Inc. 36
Clinical Trial Overview of Oxygen Biotherapeutics, Inc. 36
Clinical Trial Overview of Top Institutes / Government 37
Imperial College London 37
Clinical Trial Overview of Imperial College London 37
Denver Health and Hospital Authority 38
Clinical Trial Overview of Denver Health and Hospital Authority 38
University of California, San Francisco 39
Clinical Trial Overview of University of California, San Francisco 39
University of Pittsburgh 40
Clinical Trial Overview of University of Pittsburgh 40
Japanese Association for the Surgery of Trauma 41
Clinical Trial Overview of Japanese Association for the Surgery of Trauma 41
Southern Medical University 42
Clinical Trial Overview of Southern Medical University 42
Wolfson Medical Center 43
Clinical Trial Overview of Wolfson Medical Center 43
Ottawa Hospital Research Institute 44
Clinical Trial Overview of Ottawa Hospital Research Institute 44
The University of Texas Southwestern Medical Center at Dallas 45
Clinical Trial Overview of The University of Texas Southwestern Medical Center at Dallas 45
Baylor College of Medicine 46
Clinical Trial Overview of Baylor College of Medicine 46
Assistance Publique Hopitaux De Marseille 47
Clinical Trial Overview of Assistance Publique Hopitaux De Marseille 47
University of Virginia 48
Clinical Trial Overview of University of Virginia 48
Innsbruck Medical University 49
Clinical Trial Overview of Innsbruck Medical University 49
National Institute of General Medical Sciences 50
Clinical Trial Overview of National Institute of General Medical Sciences 50
The University of Texas Health Science Center at San Antonio 51
Clinical Trial Overview of The University of Texas Health Science Center at San Antonio 51
Sunnybrook Health Sciences Centre 52
Clinical Trial Overview of Sunnybrook Health Sciences Centre 52
University of Washington 53
Clinical Trial Overview of University of Washington 53
University of Missouri 54
Clinical Trial Overview of University of Missouri 54
Five Key Clinical Profiles 55
Appendix 87
Abbreviations 87
Definitions 87
Research Methodology 88
Secondary Research 88
About GlobalData 89
Contact Us 89
Disclaimer 89
Source 90

List of Tables

Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Hemorrhagic Shock Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10
Hemorrhagic Shock Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Hemorrhagic Shock Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Hemorrhagic Shock Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 13
Hemorrhagic Shock Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 14
Hemorrhagic Shock Therapeutics Clinical Trials, BRIC Countries, 2013* 15
Hemorrhagic Shock Therapeutics Clinical Trials, G7 Countries, 2013* 16
Hemorrhagic Shock Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Hemorrhagic Shock Therapeutics Clinical Trials, E7 Countries, 2013* 18
Hemorrhagic Shock Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21
Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Hemorrhagic Shock Therapeutics Market, Global, Terminated Clinical Trials, 2013* 23
Hemorrhagic Shock Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 24
Hemorrhagic Shock Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 26
Hemorrhagic Shock Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 28
Hemorrhagic Shock Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 29
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Sangart, Inc., 2013* 30
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 31
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Shenzhen Neptunus Pharmaceutical Company Limited, 2013* 32
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Health Ricerca e Sviluppo S.r.l, 2013* 33
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Innogene Kalbiotech Pte. Ltd., 2013* 34
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Northfield Laboratories Inc. (Inactive), 2013* 35
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Oxygen Biotherapeutics, Inc., 2013* 36
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2013* 37
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Denver Health and Hospital Authority, 2013* 38
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2013* 39
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 40
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Association for the Surgery of Trauma, 2013* 41
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Southern Medical University, 2013* 42
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Wolfson Medical Center, 2013* 43
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2013* 44
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Southwestern Medical Center at Dallas, 2013* 45
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2013* 46
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique Hopitaux De Marseille, 2013* 47
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2013* 48
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Innsbruck Medical University, 2013* 49
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of General Medical Sciences, 2013* 50
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at San Antonio, 2013* 51
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunnybrook Health Sciences Centre, 2013* 52
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2013* 53
Hemorrhagic Shock Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2013* 54

List of Figures

Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Hemorrhagic Shock Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10
Hemorrhagic Shock Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Hemorrhagic Shock Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
Hemorrhagic Shock Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 13
Hemorrhagic Shock Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 14
Hemorrhagic Shock Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15
Hemorrhagic Shock Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
Hemorrhagic Shock Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Hemorrhagic Shock Therapeutics Clinical Trials, E7 Countries (%), 2013* 18
Hemorrhagic Shock Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
Hemorrhagic Shock Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Hemorrhagic Shock Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 24
Hemorrhagic Shock Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 25
Hemorrhagic Shock Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 27
Hemorrhagic Shock Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 29
GlobalData Methodology 88

Read the full report:

Hemorrhagic Shock Global Clinical Trials Review, H2, 2013

http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trials/hemorrhagic_shock_global_clinical_trials_review.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sarah Smith
Research Advisor at Reportbuyer.com
+44 208 816 85 48
Email >
Visit website